ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
A research team at the School of Biological Sciences, the University of Hong Kong (HKU), has…
Ovarian cancer kills 14,000 women in the United States every year. It’s the fifth leading…
For more than two decades, University of Alabama at Birmingham (USA) researcher Susan Bellis, Ph.D.,…
Barbara Goff, University of Washington Ovarian cancer is the most deadly of gynecologic tumours. Fewer…
Although the outlook for people with some types of cancers has improved in the past…
Treatments for ovarian cancer have changed little over the past few decades, with surgery and…
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at…
A UNSW Sydney academic has been recognised at the 2021 NHMRC Research Excellence Awards for…
Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a…